Ensuring Continuity of Medicines Supply by Empowering Pharmacy Services with Remote Clinical Support

通过远程临床支持增强药房服务能力,确保药品供应的连续性

基本信息

  • 批准号:
    55094
  • 负责人:
  • 金额:
    $ 9.56万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Feasibility Studies
  • 财政年份:
    2020
  • 资助国家:
    英国
  • 起止时间:
    2020 至 无数据
  • 项目状态:
    已结题

项目摘要

During March 2020, community pharmacies went into overdrive as patients flocked to stores amid the panic of Covid-19\. Every pharmacy faced unprecedented demand, dispensing several times their usual prescription volumes. At the same time, they experienced stock shortages and staff absences which has added further pressure. Some pharmacies have also had to lay on additional delivery services, stretching their resources and increasing costs.The current situation has greatly impacted the pharmacy sector putting extreme burden on pharmacists on the frontline, many of which are close to breaking point. If pharmacists were to fall ill and if pharmacies were to close, this would significantly disrupt the supply of medicines across the country and reduce a valuable NHS resource for health advice at a time when this is needed the most.We considered how our technology could offer an innovative approach to supporting the sector during the Covid-19 crisis. Our new pharmacy operating system, Titan, was accredited by NHS Digital in 2019 making it the first new dispensing system to launch into the pharmacy market in over 10 years and aims to transform the way prescriptions are processed. The solution has now been implemented into 30 'trailblazer' sites across England and Wales with ambitious growth planned this year.Titan is the only cloud-based pharmacy platform on the market capable of breaking down the dispensing process into distinct digital stages. The step which crucially requires pharmacist involvement is that of clinically checking every prescription. In light of Covid-19, we explored an idea where clinical checks could be performed by remote pharmacists working from home. This would redistribute workload and greatly ease pressure from pharmacies whilst mobilising untapped resources at the same time.Our new concept of Titan Teams introduces an 'Uber' style service to pharmacies, significantly improving their chances of coping in the months ahead whilst upholding patient safety. The Business Led Innovation Grant will enable us to develop a functional system which complies with all regulatory and professional requirements. We will initially release this system to Titan Trailblazer sites within a matter of weeks and once the model is proven, then make this available to the wider pharmacy sector alongside Titan.---EXTENSION FOR IMPACT---Whereas the original project targeted 'high street' pharmacies, the Extension of the project will allow us to implement Titan Teams to large scale warehouse pharmacies. The Covid pandemic has driven greater volume to online pharmacy providers and many of these operators have seen exponential growth in their dispensing activities. This growth has put strain on their operations. Where such pharmacies use Titan, we have the potential to introduce Titan Teams allowing them to distribute and outsource the clinical services to pharmacists working from home. This innovation would make a significant contribution to the success of online pharmacy services.
2020年3月,社区药店进入超负荷运转,患者在新冠肺炎的恐慌中蜂拥至商店。每家药店都面临着前所未有的需求,配药量是平时处方数量的几倍。与此同时,他们经历了库存短缺和工作人员缺勤,这进一步增加了压力。一些药房也不得不增加送货服务,资源紧张,成本增加。目前的情况对药剂业造成了极大的影响,给前线的药剂师带来了极大的负担,其中许多药剂师已经接近崩溃。如果药剂师生病,如果药店关门,这将严重扰乱全国的药品供应,并在最需要健康建议的时候减少国民健康保险制度的宝贵健康建议资源。我们考虑了我们的技术如何能够提供一种创新的方法,在新冠肺炎危机期间支持该行业。我们的新药房操作系统Titan于2019年获得NHS Digital的认证,使其成为10多年来第一个进入药房市场的新配药系统,旨在改变处方的处理方式。该解决方案现已在英格兰和威尔士的30个“开拓者”网站实施,并计划在今年实现雄心勃勃的增长。Titan是市场上唯一能够将配药过程分解为不同数字阶段的基于云的药房平台。关键需要药剂师参与的步骤是对每一张处方进行临床检查。鉴于新冠肺炎,我们探索了一个想法,可以让远程药剂师在家工作来进行临床检查。这将重新分配工作量,极大地缓解来自药房的压力,同时调动未开发的资源。我们的新概念泰坦团队为药店引入了一项“Uber”式的服务,在维护患者安全的同时,显著提高了他们在未来几个月应对的机会。商业主导的创新基金将使我们能够开发一个符合所有监管和专业要求的功能系统。我们将在几周内将该系统初步发布到泰坦开拓者网站,一旦模型得到验证,然后将其与泰坦一起提供给更广泛的制药部门。-扩展影响--尽管最初的项目针对的是‘商业街’药店,但该项目的扩展将使我们能够将泰坦团队实施到大型仓库药店。Covid的流行推动了在线药房供应商的数量增加,其中许多运营商的配药活动出现了指数级的增长。这种增长给他们的业务带来了压力。在这样的药房使用Titan的地方,我们有可能引入Titan团队,允许他们将临床服务分发和外包给在家工作的药剂师。这一创新将对在线药房服务的成功做出重大贡献。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Studentship

相似海外基金

Treatment and Health Continuity Study Using Smartwatch and Exercise Therapy in Patients with Alcohol Use Disorders
使用智能手表和运动疗法对酒精使用障碍患者进行治疗和健康连续性研究
  • 批准号:
    23K07052
  • 财政年份:
    2023
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Evaluating Long Term Population Continuity Through Radiocarbon Dating
通过放射性碳测年评估长期人口连续性
  • 批准号:
    2314153
  • 财政年份:
    2023
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Standard Grant
Primary Care Needs for Patients with Vascular Anomalies: Improving Continuity of Care and Care Coordination in Rare Diseases
血管异常患者的初级护理需求:提高罕见疾病护理的连续性和护理协调
  • 批准号:
    10802824
  • 财政年份:
    2023
  • 资助金额:
    $ 9.56万
  • 项目类别:
Research on the Significance and Problems of the Thought and Practice of Elementary Music Education in the Postwar Period: Its Continuity from the Prewar Period
战后基础音乐教育思想与实践的意义与问题研究:战前的延续
  • 批准号:
    23K02340
  • 财政年份:
    2023
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Structured Peer-delivered ART and Reentry Community Strategy (SPARCS) to overcome barriers to HIV care continuity during community reentry from incarceration in South Africa
结构化的同伴提供的 ART 和重返社区策略 (SPARCS),以克服南非监狱出狱重返社区期间艾滋病毒护理连续性的障碍
  • 批准号:
    10700511
  • 财政年份:
    2023
  • 资助金额:
    $ 9.56万
  • 项目类别:
Towards a history of vernacular music in modern Japan: focusing on the continuity and transborder nature of performance sites
走向现代日本乡土音乐的历史:关注表演场地的连续性和跨国界性质
  • 批准号:
    23K00191
  • 财政年份:
    2023
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Skills and Employment Survey 2023: Continuity and Change
2023 年技能和就业调查:连续性与变化
  • 批准号:
    ES/X007987/1
  • 财政年份:
    2023
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Research Grant
How telemedicine affected the comprehensiveness, continuity, technical quality, and equity of care
远程医疗如何影响护理的全面性、连续性、技术质量和公平性
  • 批准号:
    484612
  • 财政年份:
    2023
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Fellowship Programs
Systems analysis and improvement to optimize opioid use disorder care quality and continuity for patients exiting jail (SAIA-MOUD).
系统分析和改进,以优化出狱患者的阿片类药物使用障碍护理质量和连续性 (SAIA-MOUD)。
  • 批准号:
    10832930
  • 财政年份:
    2023
  • 资助金额:
    $ 9.56万
  • 项目类别:
Design method of steel buckling-restrained braced frame securing business continuity considering complex and varying stress transfer mechanism
考虑复杂多变的应力传递机制确保业务连续性的钢制屈曲约束支撑框架设计方法
  • 批准号:
    23K13392
  • 财政年份:
    2023
  • 资助金额:
    $ 9.56万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了